A drug used to
treat locally advanced basal cell carcinoma (BCC) that has
come back after surgery or radiation therapy. It is also
used in patients who cannot be treated with surgery or
radiation therapy. Sonidegib is also being studied in the
treatment of other types of cancer.
Sonidegib blocks a type of
protein involved in tissue growth and repair and may block
the growth of cancer cells. It is a type of hedgehog
signaling pathway antagonist. Also called erismodegib, LDE225, and Odomzo.